PWA
WST icon

Pitcairn Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Pitcairn Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Buy
1,396
+126
+10% +$38.5K 0.05% 181
2026
Q1 		$349K Buy
1,270
+65
+5% +$16.2K 0.03% 220
2025
Q4 		$332K Buy
+1,205
New +$330K 0.03% 225

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pitcairn Wealth Advisors's WST Position: Q2 2026 in Review

Pitcairn Wealth Advisors increased its West Pharmaceutical (WST) stake by 9.9% in Q2 2026, buying an estimated $38.5K and bringing the position to 1,396 shares worth $501K. The position accounts for 0.05% of the portfolio, ranked #181.

Pitcairn Wealth Advisors first reported a position in WST in Q4 2025 and has held it in 3 quarters since. 829 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Pitcairn Wealth Advisors held 1,396 shares of West Pharmaceutical worth $501K as of Q2 2026.
  • Pitcairn Wealth Advisors bought 126 West Pharmaceutical shares in Q2 2026, an estimated $38.5K.
  • West Pharmaceutical made up 0.05% of Pitcairn Wealth Advisors's portfolio in Q2 2026, its #181 holding.
  • Pitcairn Wealth Advisors first reported a position in West Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 829 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Pitcairn Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.